Written answers

Tuesday, 25 September 2012

Department of Health

Medicinal Products Licensing

Photo of Martin FerrisMartin Ferris (Kerry North-West Limerick, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

To ask the Minister for Health if his attention has been drawn to the improvement in the condition of Cystic Fibrosis patients who are treated with a new drug Kalydeco. [40317/12]

Photo of Martin FerrisMartin Ferris (Kerry North-West Limerick, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

To ask the Minister for Health when he will license Kalydeco in order that Cystic Fibrosis sufferers may be treated with the drug. [40318/12]

Photo of Róisín ShortallRóisín Shortall (Dublin North West, Labour)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 433 and 434 together.

The HSE has recently received an application for Kayldeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, The National Centre for Pharmoeconomics will be conducting a Health Technology Assessment on the product before any reimbursement decision is made by the HSE.

Comments

No comments

Log in or join to post a public comment.